Head and neck cancers, version 2.2020

David G. Pfister, Sharon Spencer, David Adelstein, Douglas Adkins, Yoshimi Anzai, David M. Brizel, Justine Y. Bruce, Paul M. Busse, Jimmy J. Caudell, Anthony J. Cmelak, A. DimitriosColevas, David W. Eisele, Moon Fenton, Robert L. Foote, Thomas Galloway, Maura L. Gillison, Robert I. Haddad, Wesley L. Hicks, Ying J. Hitchcock, Antonio JimenoDebra Leizman, Ellie Maghami, Loren K. Mell, Bharat B. Mittal, Harlan A. Pinto, John A. Ridge, James W. Rocco, Cristina P. Rodriguez, Jatin P. Shah, Randal S. Weber, Gregory Weinstein, Matthew Witek, Frank Worden, Sue S. Yom, Weining Zhen, Jennifer L. Burns, Susan D. Darlow

Research output: Contribution to journalArticlepeer-review

82 Scopus citations

Abstract

Treatment is complex for patients with head and neck (H&N) cancers with specific site of disease, stage, and pathologic findings guiding treatment decision-making. Treatment planning for H&N cancers involves a multidisciplinary team of experts. This article describes supportive care recommendations in the NCCN Guidelines for Head and Neck Cancers, as well as the rationale supporting a new section on imaging recommendations for patients with H&N cancers. This article also describes updates to treatment recommendations for patients with very advanced H&N cancers and salivary gland tumors, specifically systemic therapy recommendations.

Original languageEnglish (US)
Pages (from-to)873-898
Number of pages26
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume18
Issue number7
DOIs
StatePublished - Jul 2020

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'Head and neck cancers, version 2.2020'. Together they form a unique fingerprint.

Cite this